hyperq™ ex
biological signal processing ltd. - צוות טכני - the hyperq™ ad software is intended to be used as an aid to stress ecg test for early detection of ischemia by means of analysis of high frequency components present within the central portion of the qrs complex
גדו-mri
rafa laboratories ltd - gadopentetic acid dimeglumine 469 mg/ml - solution for injection - gadopentetic acid - injectable contrast medium for magnetic resonance imaging (mri).
ציקלולוקס 0.5 מילימול מל
a.l. medi-market ltd. - gadoteric acid - תמיסה להזרקה - gadoteric acid 279.32 mg / 1 ml - gadoteric acid
אגרסטט
tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - תמיסה לאינפוזיה - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.
אגרסטט
tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate 0.25 mg/ml - solution for infusion - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.
אילומדין
bayer israel ltd - iloprost - תרכיז להכנת תמיסה לאינפוזיה - iloprost 0.1 mg/ml - iloprost - iloprost - peripheral arterial occlusive disease (stage 3 and 4 of fontaine's classification) in advanced arteriosclerosis, in whom surgery or angioplasty therapy is not possible.thromboangitis obliterans (buerger's disease) with critical limb ischemia in cases where revascularisation is not indicated and severe disabling raynaud's phenomenon .
טוביאז 4 מג
pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.
טוביאז 8 מג
pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.
קיאקסאלאט
sanofi israel ltd - polystyrene sulphonate sodium - אבקה להכנת תרחיף - polystyrene sulphonate sodium 99.934 % - polystyrene sulfonate - polystyrene sulfonate - treatment of hyperkalemia.
בסרמי 250 מקג 0.5 מל
aop orphan pharmaceuticals israel ltd, israel - ropeginterferon alfa-2b - תמיסה להזרקה - ropeginterferon alfa-2b 500 mcg/ml - ropeginterferon alfa-2b